DSM and Evonik Establish Joint Venture for Omega-3 Fatty Acids From Natural Marine Algae for Animal Nutrition

Wednesday, March 8, 2017 Diet & Nutrition News J E 4

KAISERAUGST, Switzerland, March 8, 2017 /PRNewswire/ --

  • Breakthrough for animal nutrition to reduce impact on ocean resources and making it more sustainable 
  • Commercial-scale facility for algal oil for salmon aquaculture and pet food to be built in the United States 
  • Further develop and produce a high value algal oil with a natural balance of EPA and DHA 

Royal DSM and Evonik today announced their intention to establish a joint venture for omega-3 fatty acid products from natural marine algae for animal nutrition. This breakthrough innovation will, for the first time, enable the production of omega-3 fatty acids for animal nutrition without using fish oil from wild caught fish, a finite resource. Evonik and DSM's alternative omega-3 source is the first to offer both EPA and DHA and will be aimed at initial applications in salmon aquaculture and pet food. The companies will together build a commercial-scale production facility in the United States.  

     (Logo: )

DSM Nutritional Products and Evonik Nutrition & Care will each hold a 50% share in the joint venture and co-own the production facility, which will be built at an existing site of Evonik and is expected to come on stream in 2019. The joint venture plans to invest around US$ 200 million in the facility (USD 100 million by each party over circa 2 years). The initial annual production capacity will meet roughly 15% of the total current annual demand for EPA and DHA by the salmon aquaculture industry. The set-up of the joint venture, to be named Veramaris and headquartered in The Netherlands, will be finalized subject to regulatory approvals and other customary closing conditions.

Evonik's and DSM's highly concentrated algal oil is a high value and pure source that will enable the animal nutrition industry to keep up with the increasing demand for these two essential omega-3 fatty acids without endangering fish stocks, contributing to healthy animal nutrition as well as to the ecological balance and biodiversity of the oceans.

The text of the full press release can be found at and

For more information: DSM Nutritional Products Herman Betten tel. +31(0)45-5782017         e-mail     Evonik Industries Matthias Ruch tel.: +49(0)201-177-3348 e-mail:





You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Scar Treatment Market Worth $34.5 Billion by 2025 ...
Successful Clinical Results for GenedriveŪ HCV Ass...